Patrick Ott, Md, Phd

This study tested a personalized vaccine made from each patient's unique melanoma mutations. The goal was to see if the vaccine is safe and can train the immune system to fight remaining cancer cells. 15 people with advanced melanoma participated, and researchers checked for side…